Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

NCT01163838 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was redesigned based on FDA feedback.

Conditions

Hypercholesterolemia
Dyslipidemia

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: 1 mg/kg every 2 weeks
BIOLOGICAL: 2 mg/kg every 4 weeks
BIOLOGICAL: 4 mg/kg every 4 weeks
BIOLOGICAL: 4 mg/kg every 8 weeks
BIOLOGICAL: 8 mg/kg every 8 weeks
BIOLOGICAL: 12 mg/kg every 8 weeks

Sponsor

Pfizer